Pilot/Technologies Recipient: Dr. Xuebiao Yao

Xuebiao Yao, PhD

Professor, Department of Physiology
Morehouse School of Medicine (MSM)

Supported Research

ACTSI Support

  • Funding: Pilot Grants and Research Technologies pilot project recipient
  • Equipment:
    1. Deconvolution Microscope to enhance the existing molecular imaging capabilities at MSM (TTR new technologies equipment recipient - $320,000)-Located at MSM; and
    2. Carl Zeiss Palm System for the visualization of single molecules (TTR new technologies equipment recipient-only two others in the U.S. - $225,811) Co-funded by MSM R-CENTER-Located at MSM

Publication Selections

Cancer Cell | CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3

Dr. Yao works on chromosomal segregation during cell division and what goes wrong during tumorigenesis. With new agent development support from the ACTSI and co-funding from the MSM RCMI G20 grant, Dr. Yao, along with his collaborative team at Emory and MSM, have identified new microtuble and signal transduction pathways as drug targets.

EMBO Reports | TIP150 interacts with and targets MCAK to the microtubule plus-ends

The Jorunal of Biological Chemistry | Phospho-regulated ACAP4-ezrin interaction is essential for histamine-stimulated parietal cell secretion

Upcoming Events

    View All Events

    Latest News


    ACTSI-supported OculoStaple Wins Again

    Atlanta Clinical & Translational Science Institute (ACTSI)-supported team, OculoStaple wins second place in the 2015 InVenture Prize at Georgia Tech. Team members Jackie Borinski, Mohamad Ali Najia, and Drew Padilla, all biomedical...


    Infographic: What are the Phases of Clinical Trials?